Phase II four-arm RCT in 110 high-risk women: low-dose tamoxifen with or without intermittent caloric restriction raised SHBG and IGFBP-3 and lowered IGF-I over 6 months; caloric restriction raised adiponectin. Tamoxifen mildly worsened quality of life.
RCTn = 110
Serrano et al. Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women